Piramal Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Piramal Pharma Ltd. on BSE

Load latest

Piramal Pharma Ltd.

28 Sep 2023

195.10

1.60%

Company Update

Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Please see attached disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for successful closure of US FDA Inspection at Piramal Pharma''s manufacturing facility located at Bethlehem, USA.

pdf

Piramal Pharma Ltd.

27 Sep 2023

195.10

1.60%

Company Update

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Outcome of Rights Issue Committee Meeting

pdf

Piramal Pharma Ltd.

12 Sep 2023

195.10

1.60%

Company Update

Piramal Pharma Ltd - 543635 - Intimation Under Regulation 30 Of Securities And Exchange Board Of …

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as per attachment

pdf

Piramal Pharma Ltd.

08 Sep 2023

195.10

1.60%

Company Update

Piramal Pharma Ltd - 543635 - Sustainability Report Of Piramal Pharma Limited ('The Company') For Financial …

BSE India

Sustainability Report of Piramal Pharma Limited ("the Company") for financial year 2022-23

pdf

Piramal Pharma Ltd.

05 Sep 2023

195.10

1.60%

SAST

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal & Others

pdf

Piramal Pharma Ltd.

05 Sep 2023

195.10

1.60%

SAST

Piramal Pharma Ltd - 543635 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal & Others

pdf

Piramal Pharma Ltd.

05 Sep 2023

195.10

1.60%

SAST

Piramal Pharma Ltd - 543635 - Revised Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piraal & Others

pdf

Piramal Pharma Ltd.

28 Aug 2023

195.10

1.60%

SAST

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal

pdf

Piramal Pharma Ltd.

25 Aug 2023

195.10

1.60%

SAST

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal & Others

pdf

Piramal Pharma Ltd.

25 Aug 2023

195.10

1.60%

SAST

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal & Others

pdf

VOTE: Is Piramal Pharma Ltd. worth buying?

364 Votes:

Buy 82.97%

Sell 11.26%

Hold 5.77%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf link